Dissociation of body growth and adipose deposition effects of growth hormone in oMt1a-oGH transgenic mice
- PMID: 15307663
Dissociation of body growth and adipose deposition effects of growth hormone in oMt1a-oGH transgenic mice
Abstract
Chronic highly elevated expression of a growth hormone (GH) transgene enhances overall body growth with minimal adipose accretion, while moderate levels of circulating GH fail to enhance body growth yet promote adipose deposition. These findings suggest that the growth response to GH can be dissociated from adipose effects. This hypothesis was tested in the oMtla-oGH transgenic mouse model by titrating circulating GH levels through variable induction of transgene expression. Circulating GH levels in female transgenics were approximately 49, 132, and 750 ng/ml in response to the transgene stimulus at 0, 15, and 25 mM zinc sulfate, respectively. The highest level of circulating GH generated the largest body weight with the smallest fat accrual while the intermediate GH level generated a body weight equivalent to that for the highest GH but the heaviest gonadal fat pads. The lowest GH levels did not increase body size but did enlarge fat depots. Animals exposed to the highest level of GH had an extended growth phase relative to lower GH levels and the nontransgenic controls. In contrast, the duration of the growth phase for the 0 and 15 mM zinc stimulated transgenics was abbreviated relative to the growth phase of the control animals. The two highest levels of circulating GH increased all forms of the GH receptor, IGF-I, and hepatic lipoprotein lipase mRNA. The growth differential observed for the 0 vs. the 15 mM zinc stimulated transgenics may reflect the preferential increase in the full length GH receptor mRNA and the induction of the smaller IGF-I transcripts with the higher circulating GH while the lipid accrual paralleled the disproportionate induction of the truncated GH receptor mRNA form. Liver and bone content of zinc, manganese, copper, and iron primarily reflected dietary zinc supplementation and did not appear to play a role in the differential growth response. The dissociation of GH effects on growth and adipogenesis as a function of circulating GH levels suggests that the level of GHR and IGF-I expression acts through a threshold mechanism and low expression results in adipogenesis while high expression generates body growth.
Similar articles
-
Effects of pre and antenatal elevated and chronic oMt1a-oGH transgene expression on adipose deposition and linear bone growth in mice.Growth Dev Aging. 2001 Spring;65(1):3-13. Growth Dev Aging. 2001. PMID: 11548870
-
Body composition of inactivated growth hormone (oMt1a-oGH) transgenic mice: generation of an obese phenotype.Growth Dev Aging. 1997 Fall-Winter;61(3-4):169-79. Growth Dev Aging. 1997. PMID: 9546108
-
Consequences of limited exposure to elevated growth hormone in the mature oMt1a-oGH transgenic mouse.Growth Dev Aging. 1998 Autumn;62(3):87-93. Growth Dev Aging. 1998. PMID: 9894170
-
A transgenic model to determine the physiological role of liver-derived insulin-like growth factor I.Minerva Endocrinol. 2002 Dec;27(4):299-311. Minerva Endocrinol. 2002. PMID: 12511852 Review.
-
Technologies for the control of fat and lean deposition in livestock.Vet J. 2004 May;167(3):242-57. doi: 10.1016/j.tvjl.2003.10.020. Vet J. 2004. PMID: 15080873 Review.
Cited by
-
Growth hormone enhances arachidonic acid metabolites in a growth hormone transgenic mouse.Lipids. 2011 Jun;46(6):495-504. doi: 10.1007/s11745-011-3548-y. Epub 2011 Mar 27. Lipids. 2011. PMID: 21442273 Free PMC article.
-
Growth hormone regulates the balance between bone formation and bone marrow adiposity.J Bone Miner Res. 2010 Apr;25(4):757-68. doi: 10.1359/jbmr.091015. J Bone Miner Res. 2010. PMID: 19821771 Free PMC article.
-
Elevated GH/IGF-I, due to somatotrope-specific loss of both IGF-I and insulin receptors, alters glucose homeostasis and insulin sensitivity in a diet-dependent manner.Endocrinology. 2011 Dec;152(12):4825-37. doi: 10.1210/en.2011-1447. Epub 2011 Oct 11. Endocrinology. 2011. PMID: 21990313 Free PMC article.
-
Developmental programming: the role of growth hormone.J Anim Sci Biotechnol. 2015 Feb 12;6(1):8. doi: 10.1186/s40104-015-0001-8. eCollection 2015. J Anim Sci Biotechnol. 2015. PMID: 25774292 Free PMC article.